Topic · page 42 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,641–1,680 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

Eur J Heart Fail24 Nov 2023
The Different Risk of New-Onset, Chronic, Worsening, and Advanced Heart Failure: A Systematic Review and Meta-Regression Analysis
Meta-analysis
Europace23 Nov 2023
Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making
Cohort study
Eur J Prev Cardiol22 Nov 2023
Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study
Cohort study
JACC Heart Fail22 Nov 2023
Skeletal Muscle Involvement in Patients With Truncations of Titin and Familial Dilated Cardiomyopathy
Cross-sectional study
JACC Heart Fail22 Nov 2023
Prevalence of Subclinical Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
Cross-sectional study
JACC Cardiovasc Imaging22 Nov 2023
Clinical Utility of Computed Tomography–Derived Myocardial Extracellular Volume Fraction: A Systematic Review and Meta-Analysis
Meta-analysis
Eur J Heart Fail22 Nov 2023
Growth Differentiation Factor-15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR Program
Secondary analysis
Eur J Heart Fail22 Nov 2023
Guideline-Directed Medical Therapy in Severe Heart Failure with Reduced Ejection Fraction: An Analysis from the HELP-HF Registry
Cohort study
Eur J Prev Cardiol22 Nov 2023
Severe biventricular cardiomyopathy in both current and former long-term users of anabolic–androgenic steroids
Cross-sectional study
Eur J Heart Fail21 Nov 2023
Hypotension in Heart Failure is Less Harmful if Associated with High or Increasing Doses of Heart Failure Medication: Insights from the Swedish Heart Failure Registry
Cohort study
Eur J Heart Fail20 Nov 2023
Early Changes in Renal Function During Rapid Up-Titration of Guideline-Directed Medical Therapy Following an Admission for Acute Heart Failure
Secondary analysis
Eur J Heart Fail16 Nov 2023
Short-Term Effects of Sacubitril/Valsartan Therapy on Myocardial Oxygen Consumption and Energetic Efficiency of Cardiac Work in Heart Failure with Reduced Ejection Fraction: A Randomized Controlled Study
Randomised controlled trial
J Am Coll Cardiol14 Nov 2023
Deep Learning–Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes
Cohort study
Circulation13 Nov 2023
Lifestyle Walking Intervention for Patients With Heart Failure With Reduced Ejection Fraction: The WATCHFUL Trial
Randomised controlled trial
Europace10 Nov 2023
Identification of concealed cardiomyopathy using next-generation sequencing–based genetic testing in Korean patients initially diagnosed with idiopathic ventricular fibrillation
Cohort study
Eur J Heart Fail9 Nov 2023
Comprehensive Vasodilatation in Women with Acute Heart Failure: Novel Insights from the GALACTIC Randomized Controlled Trial
Secondary analysis
Eur J Heart Fail9 Nov 2023
Long-Term Outcome After Upgrade to Cardiac Resynchronization Therapy: A Propensity Score-Matched Analysis
Cohort study
JACC Heart Fail8 Nov 2023
30- and 60-Day Readmission Rates for Children With Heart Failure in the United States
Cohort study
JACC Heart Fail8 Nov 2023
Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
Cohort study
JACC Heart Fail8 Nov 2023
Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study
Secondary analysis
JACC Heart Fail8 Nov 2023
Rationale, Design, and Patient Characteristics of a Cluster-Randomized Pragmatic Trial to Improve Mineralocorticoid Antagonist Use
Randomised controlled trial
JACC Heart Fail8 Nov 2023
Impact of Digital Health Technology on Quality of Life in Patients With Heart Failure
Randomised controlled trial
Circulation6 Nov 2023
Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease
Cohort study
Circulation6 Nov 2023
Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy
Meta-analysis
JACC Heart Fail6 Nov 2023
Health Status in Heart Failure and Cancer: Analysis of the Medicare Health Outcomes Survey 2016-2020
Cross-sectional study
Eur Heart J6 Nov 2023
Fulminant myocarditis proven by early biopsy and outcomes
Cohort study
Eur Heart J4 Nov 2023
Disparities in donor heart acceptance between the USA and Europe: clinical implications
Cohort study
Eur J Heart Fail3 Nov 2023
Clinical Characteristics and Prognosis of Patients with Isolated Cardiac Sarcoidosis: Insights from the ILLUMINATE-CS Study
Secondary analysis
JAMA Cardiol1 Nov 2023
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management
Research article
JAMA Cardiol1 Nov 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial
Randomised controlled trial
Eur J Heart Fail31 Oct 2023
Exercise-Based Cardiac Rehabilitation for Adults with Heart Failure – 2023 Cochrane Systematic Review and Meta-Analysis
Meta-analysis
Eur J Heart Fail31 Oct 2023
Outcomes at One Year in Women with Peripartum Cardiomyopathy: Findings from the ESC EORP PPCM Registry
Cohort study
J Am Coll Cardiol31 Oct 2023
Patients With Hypertrophic Cardiomyopathy and Normal Genetic Investigations Have Few Affected Relatives
Cohort study
Eur J Prev Cardiol27 Oct 2023
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset
Cohort study
N Engl J Med26 Oct 2023
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis
Randomised controlled trial
JACC Heart Fail25 Oct 2023
SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction
Cohort study
JACC Heart Fail25 Oct 2023
Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure
Cohort study
JACC Heart Fail18 Oct 2023
Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension: Post-Hoc Analysis of the EXPLORER-HCM Trial
Secondary analysis
Eur J Heart Fail18 Oct 2023
Safety of Continuing Mineralocorticoid Receptor Antagonist Treatment in Patients with Heart Failure with Reduced Ejection Fraction and Severe Kidney Disease: Data from Swedish Heart Failure Registry
Cohort study
Eur J Heart Fail17 Oct 2023
Circulating Neutrophil-Related Proteins Associate with Incident Heart Failure and Cardiac Dysfunction: The ARIC Study
Cohort study

All 1,928 Briefs in ExploreShowing Briefs 1,641–1,680 of 1,928, newest first